(Q35030190)

English

Heparin-protein interactions

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

Heparin-protein interactions (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Robert J. Linhardt

2

object named as

Robert J Linhardt

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Ishan Capila

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Angewandte Chemie

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

391-412

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Observations on the structure of the barium salt of heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

An update on heparins at the beginning of the new millennium

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Structure of the antithrombin-binding site in heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Correlation between structure and function of heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Specificity studies on the heparin lyases from Flavobacterium heparinum

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

More to "heparin" than anticoagulation

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Functions of cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

N.m.r. and molecular-modelling studies of the solution conformation of heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Order out of complexity--protein structures that interact with heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Conformational equilibria of alpha-L-iduronate residues in disaccharides derived from heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

NMR solution conformation of heparin-derived hexasaccharide

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

NMR solution conformation of heparin-derived tetrasaccharide

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin structure and interactions with basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Polysaccharide lyases

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Characterization of recombinant human glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Human homolog of Caenorhabditis elegans sqv-3 gene is galactosyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Repetitive Ser-Gly Sequences Enhance Heparan Sulfate Assembly in Proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Biosynthesis of heparin. The D-glucuronosyl- and N-acetyl-D-glucosaminyltransferase reactions and their relation to polymer modification

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Pharmacodynamics, clinical indications, and adverse effects of heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Importance of specific amino acids in protein binding sites for heparin and heparan sulfate

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interaction of heparin and antithrombin III. The role of O-sulfate groups

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Diversity does make a difference: fibroblast growth factor-heparin interactions

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Thermodynamic analysis of the heparin interaction with a basic cyclic peptide using isothermal titration calorimetry

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interaction of heparin with synthetic antithrombin III peptide analogues

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

On the application of polyelectrolyte "limiting laws" to the helix-coil transition of DNA. I. Excess univalent cations

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

A detailed 1H and 13C NMR study of a repeating disaccharide of hyaluronan: the effects of temperature and counterion type

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Ion effects on ligand-nucleic acid interactions

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Thermodynamics of ligand-nucleic acid interactions

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin-induced conformational change and activation of mucus proteinase inhibitor.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interaction of heparin with annexin V.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interaction of soluble and surface-bound heparin binding growth-associated molecule with heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin binding and augmentation of C1 inhibitor activity.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interterminal distance and flexibility of a triantennary glycopeptide as measured by resonance energy transfer

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Two-dimensional affinity resolution electrophoresis demonstrates that three distinct heparin populations interact with antithrombin III.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Nature of the interaction of heparin with acidic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin binding site, conformational change, and activation of antithrombin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Serpins: the uncut version

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Denaturation behavior of antithrombin in guanidinium chloride. Irreversibility of unfolding caused by aggregation.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The anticoagulant activation of antithrombin by heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The role of Arg46 and Arg47 of antithrombin in heparin binding.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Some properties of an esterase derived from preparations of the first component of complement

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

FGFs, heparan sulfate and FGFRs: complex interactions essential for development

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The transforming growth factor-betas. A new family of immunoregulatory molecules

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Definition, function and pathophysiological significance of chemokine receptors

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The biology of chemokines and their receptors

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Differential binding of chemokines to glycosaminoglycan subpopulations

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Glycosaminoglycans Mediate Cell Surface Oligomerization of Chemokines

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

A model of the platelet factor 4 complex with heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Defining the interleukin-8-binding domain of heparan sulfate

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Characterization of the stromal cell-derived factor-1alpha-heparin complex

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Annexins and membrane dynamics

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Calcium-Dependent Heparin-Like Ligands For L-Selectin in Nonlymphoid Endothelial Cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Glycosaminoglycan binding properties of annexin IV, V, and VI.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Annexin V--heparin oligosaccharide complex suggests heparan sulfate--mediated assembly on cell surfaces

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Apolipoprotein E and atherosclerosis: insight from animal and human studies

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interaction of the N-terminal domain of apolipoprotein E4 with heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The CD4 antigen: physiological ligand and HIV receptor

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Host cyclophilin A mediates HIV-1 attachment to target cells via heparans

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Specific incorporation of cyclophilin A into HIV-1 virions

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Functional association of cyclophilin A with HIV-1 virions

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Vitronectin binds to the gonococcal adhesin OpaA through a glycosaminoglycan molecular bridge

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Adherence of pilus- Opa+ gonococci to epithelial cells in vitro involves heparan sulfate

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Entry of OpaA+ gonococci into HEp-2 cells requires concerted action of glycosaminoglycans, fibronectin and integrin receptors

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Selectin ligands

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Endothelial heparan sulfate proteoglycans that bind to L-selectin have glucosamine residues with unsubstituted amino groups

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

A comparative analysis of the primary sequences and characteristics of heparinases I, II, and III from Flavobacterium heparinum

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Cloning and expression of heparinase I gene from Flavobacterium heparinum

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparinase III from Flavobacterium heparinum: cloning and recombinant expression in Escherichia coli

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparinase I from Flavobacterium heparinum. Identification of a critical histidine residue essential for catalysis as probed by chemical modification and site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II.

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparinase inhibits neovascularization

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Human heparanase. Purification, characterization, cloning, and expression

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

A rapid quantitative assay for the detection of mammalian heparanase activity

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparanase, a potential regulator of cell-matrix interactions

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Substrate specificity of heparanases from human hepatoma and platelets

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Conformation of the Unsaturated Uronic Acid Residues of Glycosamtnoglycan Disaccharides

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Docking of Glycosaminoglycans to Heparin-Binding Proteins: Validation for aFGF, bFGF, and Antithrombin and Application to IL-8

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020201%2941%3A3%3C390%3A%3AAID-ANIE390%3E3.0.CO%3B2-B

21 January 2018

Identifiers

10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35030190&oldid=1567184892"